319
Views
84
CrossRef citations to date
0
Altmetric
Research Article

α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles

, , &
Pages 53-60 | Published online: 29 Sep 2008
 

Abstract

#102 -Tocopherol, or vitamin E (VE), is widely used as a strong antioxidant in many medical and cosmetic applications, but is rapidly degraded, because of its light, heat and oxygen sensitivity. Thus, all of its formulation has to avoid contact with light, heat or air. Drug loaded carriers are an attractive opportunity, especially if they are made for bioacceptable macromolecules such as vegetal proteins. For instance, gliadins, extracted from wheat gluten, generate nanoparticles by a desolvatation method and may interact with epidermal keratin for therapeutic or cosmetic formulations. Their lipophilic drug loading capacities have been investigated. The VE loaded gliadin nanoparticles have been characterized by their size, by their zeta potential, by their VE payload, and by their entrapment efficiency. When VE loaded, the gliadin particle size is ~900 nm and their charge is close to zero. They are suitable VE drug carriers with an optimum encapsulation rate ~100 VE #181;g/ gliadin mg with an efficiency of more than 77%. The release behaviour of VE loaded nanoparticles may be interpreted as a 'burst effect', followed by a diffusion process through an homogeneous sphere.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.